Jingya Guo

3.1k total citations · 3 hit papers
23 papers, 1.9k citations indexed

About

Jingya Guo is a scholar working on Immunology, Oncology and Infectious Diseases. According to data from OpenAlex, Jingya Guo has authored 23 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 8 papers in Oncology and 3 papers in Infectious Diseases. Recurrent topics in Jingya Guo's work include Immune Cell Function and Interaction (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Immunotherapy and Immune Responses (7 papers). Jingya Guo is often cited by papers focused on Immune Cell Function and Interaction (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Immunotherapy and Immune Responses (7 papers). Jingya Guo collaborates with scholars based in China, United States and United Kingdom. Jingya Guo's co-authors include Yang‐Xin Fu, Hua Peng, Haidong Tang, Yong Liang, Yang Wang, Wei Liang, Xiaoxiao Wang, Jieyi Wang, Lukasz K. Chlewicki and Yuan Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Jingya Guo

22 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade

2016 382 citations Haidong Tang, Yang Wang et al. Cancer Cell profile →
PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade

2020 370 citations Peng Qi, Xiangyan Qiu et al. Nature Communications profile →
Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis

2020 307 citations Lang Rao, Lei Wu et al. Nature Communications profile →

Peers

Countries citing papers authored by Jingya Guo

Since Specialization

Citations

This map shows the geographic impact of Jingya Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingya Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingya Guo more than expected).

Fields of papers citing papers by Jingya Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingya Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingya Guo. The network helps show where Jingya Guo may publish in the future.

Co-authorship network of co-authors of Jingya Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Jingya Guo. A scholar is included among the top collaborators of Jingya Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingya Guo. Jingya Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Repurposing Vancomycin as a Potential Antiviral Agent Against PEDV via nsp13 Helicase Inhibition 2025 ·Animals ·(unknown), (unknown), Jingya Guo, (unknown), Fei Liu, Yanke Shan	0
2	Concurrent intratumoural Treg cell depletion and CD8+ T cell expansion via a cleavable anti-4-1BB–interleukin-15 fusion protein 2024 ·Nature Biomedical Engineering ·(unknown), Zhengxue Han, (unknown), (unknown), Jingya Guo, Yong Liang, Shijie Li, (unknown), Zhenhua Ren, Hua Peng, Yang‐Xin Fu	3
3	Hypoxia-induced activation of HIF-1alpha/IL-1beta axis in microglia promotes glioma progression via NF-κB-mediated upregulation of heparanase expression 2024 ·Biology Direct ·(unknown), Jingya Guo, (unknown), Wěi Li, (unknown), (unknown), Quanwu Zhang	6
4	An engineered concealed IL-15-R elicits tumor-specific CD8+T cell responses through PD-1-cis delivery 2022 ·The Journal of Experimental Medicine ·(unknown), (unknown), Jingya Guo, (unknown), (unknown), Yong Liang, Wenyan Wang, Hua Peng, Yang‐Xin Fu	29
5	Cancer cell-intrinsic XBP1 drives immunosuppressive reprogramming of intratumoral myeloid cells by promoting cholesterol production 2022 ·Cell Metabolism ·(unknown), Yazhen Huo, Shixin Zhou, Jingya Guo, Xiaotu Ma, Tao Li, (unknown), Likun Wang	109
6	Tumor-conditional IL-15 pro-cytokine reactivates anti-tumor immunity with limited toxicity 2021 ·Cell Research ·Jingya Guo, Yong Liang, (unknown), (unknown), (unknown), Jiankun Zhu, Yang‐Xin Fu, Hua Peng	69
7	Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis breakdown → 2020 ·Nature Communications ·Lang Rao, Lei Wu, Zhida Liu, Rui Tian, Guocan Yu, Zijian Zhou, Kuikun Yang, (unknown), Anli Zhang, (unknown), Wenjing Sun, Xu Han, Jingya Guo, Andrew Li, Hongmin Chen, Zhi‐Jun Sun, Yang-Xin Fu, Xiaohong Chen	307
8	PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade breakdown → 2020 ·Nature Communications ·Peng Qi, Xiangyan Qiu, Zihan Zhang, Silin Zhang, Yuanyuan Zhang, Yong Liang, Jingya Guo, Hua Peng, Mingyi Chen, Yang‐Xin Fu, Haidong Tang	370
9	Multiple Xanthomonas campestris pv. campestris 8004 type III effectors inhibit immunity induced by flg22 2020 ·Planta ·Yan Huang, Tongqi Li, Ting Xu, (unknown), Jingya Guo, Yi Cai	9
10	A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control 2019 ·Nature Communications ·Zhichen Sun, Zhenhua Ren, Kaiting Yang, Zhida Liu, Shuaishuai Cao, Sisi Deng, Lily Xu, Yong Liang, Jingya Guo, Yingjie Bian, Hairong Xu, Jiyun Shi, Fan Wang, Yang-Xin Fu, Hua Peng	147
11	Tumor-infiltrating regulatory T lymphocytes orchestrate oncogenic PAK1-conferred immune evasion in clear-cell renal cell carcinoma 2019 ·European Urology Supplements ·Yang Qu, (unknown), Qi Bai, Jing Xu, Jingya Guo	1
12	The chloroplast genome of the marine microalga Tisochrysis lutea 2019 ·SHILAP Revista de lepidopterología ·(unknown), Jingya Guo, Elisabeth A. Mudd, Jerry Wong, Jean‐Marc Schwartz, Anil Day	11
13	Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance 2018 ·Nature Communications ·Yong Liang, Haidong Tang, Jingya Guo, Xiangyan Qiu, (unknown), Zhenhua Ren, Zhichen Sun, Yingjie Bian, Lily Xu, Hairong Xu, (unknown), Yanfei Han, Haidong Dong, Hua Peng, Yang-Xin Fu	69
14	Dual Targeting of Innate and Adaptive Checkpoints on Tumor Cells Limits Immune Evasion 2018 ·Cell Reports ·Xiaojuan Liu, Longchao Liu, Zhenhua Ren, Kaiting Yang, Hairong Xu, Yan Luan, Kai Fu, Jingya Guo, Hua Peng, Mingzhao Zhu, Yang-Xin Fu	107
15	Salivary factor LTRIN from Aedes aegypti facilitates the transmission of Zika virus by interfering with the lymphotoxin-β receptor 2018 ·Nature Immunology ·Lin Jin, Xiaomin Guo, Chuanbin Shen, Hao Xue, Peng Sun, Pengpeng Li, Tao Xu, Chunmiao Hu, (unknown), Hongning Zhou, Mingdong Yang, Cheng‐Feng Qin, Jingya Guo, Hua Peng, Mingzhao Zhu, Gong Cheng, Xiaopeng Qi, Ren Lai	81
16	Molecular cloning and functional characterisation of an H+-pyrophosphatase from Iris lactea 2017 ·Scientific Reports ·Lin Meng, Shanshan Li, Jingya Guo, Qiang Guo, Peichun Mao, Xiaoxia Tian	11
17	Vaccines targeting preS1 domain overcome immune tolerance in hepatitis B virus carrier mice 2017 ·Hepatology ·Yingjie Bian, Zheng Zhang, Zhichen Sun, Juanjuan Zhao, (unknown), Yang Wang, Sherry Fu, Jingya Guo, Longchao Liu, Lishan Su, Fu‐Sheng Wang, Yang‐Xin Fu, Hua Peng	45
18	CTLA-4 Limits Anti-CD20–Mediated Tumor Regression 2016 ·Clinical Cancer Research ·Zhenhua Ren, Jingya Guo, Jing Liao, Yan Luan, Zhida Liu, Zhichen Sun, (unknown), Yong Liang, Hua Peng, Yang‐Xin Fu	34
19	Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade breakdown → 2016 ·Cancer Cell ·Haidong Tang, Yang Wang, Lukasz K. Chlewicki, Yuan Zhang, Jingya Guo, Wei Liang, Jieyi Wang, Xiaoxiao Wang, Yang‐Xin Fu	382
20	Innate lymphotoxin receptor mediated signaling promotes HSV-1 associated neuroinflammation and viral replication 2015 ·Scientific Reports ·Yong Liang, Kaiting Yang, Jingya Guo, (unknown), Yang‐Xin Fu, Hua Peng	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact